Ulcer Clinical Trial
Official title:
Effects of Compression in Mixed Ulcers
About 15% to 30% of patients with venous leg ulcers have a peripheral arterial disease (PAD)
associated. The compression band is still a controversial issue in this context. It allows
the reduction of venous hypertension and edema, but it could potentially degrade the
arterial infusion of high levels of compression. The French High Authority for Health (HAS)
defines mixed ulcers by IPS between 0.5 and 0.9. Investigators distinguish mixed ulcers
blood predominance for IPS between 0.5 and 0.7; and mixed ulcers predominantly venous blood
with moderate involvement for IPS values between 0.7 and 0.9.
Several studies have shown that IPS> 0.8 allowed a high compression, between 30 and 40 mmHg.
In the case of mixed ulcers with IPS between 0.6 and 0.8, the HAS recommends using a lighter
compression, bit by elastic bands (exercising low power compression at rest) under medical
supervision, informing the patient to remove the bandage if pain or aggravation. It is
therefore necessary to adapt the compression therapy in case of venous ulcers associated
with arterial disease by providing a lower compression 30 mmHg short stretch. For HAS, IPS
<0.6 against indicates compression.
A recent study showed that compression bit elastic bands could not only improve venous
return, but it would also increase the distal arterial flow in a patient population with
mixed ulcers. In this study, 25 patients had between IPS 0.5 and 0.8; or for certain
patients below the threshold of 0.6 indicates that against a compression according to HAS.
To our knowledge this is the only study that has examined the effect of compression on blood
perfusion.
Objectives:
- Principal: Study the distal arterial infusion in a patient population with mixed ulcers
under compression leg with little elastic bands
- Secondary: To evaluate the safety of the little compression elastic band in a mixed
population of patients with leg ulcers
Methodology :
- Study non-interventional prospective single-center that evaluates professional practice
from 25 patients with mixed leg ulcers and followed in the vascular medicine department
of St. Joseph Hospital Group Paris.
- Applying a bit compression elastic bandages to a pressure level between 30 and 40mmHg.
- Anonymous data reports on the grid standardized collection, by a numbering system from
1 to 30 and then captured on a computer file
- Age, risk factors and cardiovascular history of the patients,
- Age, ulcer description
- Palpation of pulse
- morphological vascular profile of patients with arterial and venous Doppler dating
less than a year,
- Series following data before installation, 10 minutes after application and 24
hours after installation of the inelastic compression:
o Evaluation of tolerance:
- measurement of pain numeric scale (NS)
- description of the skin condition of the leg by a dermatologist, seeking signs of
suffering skin after application of compression: possible appearance of erythema,
cyanosis, purpura. A search particularly in areas of bony prominences and the
banks of the ulcer.
o distal arterial pressures of the compression carrier leg:
- IPS (systolic pressure index): ankle and arm pressures will be measured with a
cuff and a continuous Doppler. GPI is calculated by dividing the lowest pressure
at the ankle (at the dorsalis pedis or posterior tibial artery) by the humeral
pressure.
- Transcutaneous Oxygen Pressure (TcPO2) o Measuring pressure exerted by low elastic
bandages by Kikuhime® system.
In case of bad tolerance of compression at any time after installation, the compression will
be removed and the study stopped for the patient in question. Poor tolerance is defined by
an increase in pain than or equal to 2 points on the digital scale.
expected benefits for patients:
- Demonstration of good tolerance, defined as no worsening of the skin condition and the
lack of increase in pain associated with inelastic compression.
- Demonstration of no worsening of arterial infusion by inelastic compression.
- Evidence of improved distal arterial hemodynamics (increased IPS and tcpO2) with a
little elastic compression, which validate the results of the only study ever conducted
on the subject.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT02565264 -
Effect of Plasma Derived Exosomes on Cutaneous Wound Healing
|
Early Phase 1 | |
Recruiting |
NCT00926809 -
H. Pylori Eradication on Healing of Iatrogenic Gastric Ulcer by Endoscopic Mucosal Resection
|
Phase 4 | |
Completed |
NCT00633035 -
Comparison of Esomeprazole and Famotidine for Stress Ulcer Prophylaxis in Neurosurgical Intensive Care Unit
|
Phase 4 | |
Completed |
NCT00402727 -
Comparison of Sequential IV/PO Moxifloxacin With IV Piperacillin/Tazobactam Followed by PO Amoxicillin/Clavulanic Acid in Patients With a Complicated Skin and Skin Structure Infection
|
Phase 3 | |
Completed |
NCT06464250 -
The Effect of Bundle Approach on Foot Care Behaviors and Diabetic Wound Healing in Patients
|
N/A | |
Not yet recruiting |
NCT03250533 -
Analysis of the Effects of LED Phototherapy and Electrical Stimulation in the Healing of Diabetic Ulcers
|
N/A | |
Terminated |
NCT01657318 -
Olivamine-containing Products in the Management of Patients With Nonhealing Lower Extremity Ulcers
|
||
Completed |
NCT02535481 -
Epidermal Grafting in Wound Healing
|
N/A | |
Withdrawn |
NCT01215058 -
Gastroprotective Agent Compliance in Patients at Risk Suffering From a Gastrointestinal(GI) Ulcer
|
N/A | |
Recruiting |
NCT04210089 -
Total Contact Soft Cast in Diabetic Foot Ulcers
|
N/A | |
Completed |
NCT04573959 -
Validation of CapsoVision CapsoCam® SV-3 Capsule Endoscopy System
|
N/A | |
Recruiting |
NCT03347812 -
Clinical Study for Evaluating the Safety and Efficacy of Total Endovascular Aortic Arch Repair
|
N/A | |
Active, not recruiting |
NCT02973893 -
Study of VF001-DP in Patients With Chronic Venous Leg Ulcers
|
Phase 2 | |
Terminated |
NCT01853384 -
Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers
|
Phase 3 | |
Completed |
NCT00221143 -
Stem Cell Study for Patients With Leg Ulcer/Gangrene
|
Phase 1/Phase 2 | |
Completed |
NCT00158483 -
Anti-Herpetic Treatment of Genital Ulcer : Effect on HIV & Herpes Shedding (ANRS 1212)
|
Phase 2 | |
Completed |
NCT00660049 -
Feasibility Study of a Novel Device for Chronic Wounds
|
N/A | |
Completed |
NCT00450216 -
Efficacy and Safety Study of HZT-501 in Subjects Requiring Nonsteroidal Anti-Inflammatory Drug (NSAID) Treatment
|
Phase 3 | |
Completed |
NCT00164424 -
Episodic Acyclovir Therapy for Genital Ulcers
|
Phase 2/Phase 3 | |
Completed |
NCT02733978 -
Ozone Therapy in the Treatment of Digital Ulcers in Patients With Systemic Sclerosis
|
N/A |